Add BrightSurf on Google Email

Mayo Clinic


Mayo research team identifies genes that increase risk for triple-negative breast cancer

A Mayo Clinic research team has identified specific genes associated with an increased risk for developing triple-negative breast cancer. Alternations in BARD1, BRCA1, BRCA2, PALB2 and RAD51D genes were linked to a high risk for this subtype of breast cancer, while mutations in BRIP1 and RAD51C genes showed a moderate risk.

SourceMayo Clinic·JournalJNCI Journal of the National Cancer Institute·DateAug 6, 2018

Mayo Clinic researchers uncover methods to quantify the yips and golfer's cramp

Researchers at Mayo Clinic have identified a neurological cause for the yips in golfers, which can be measured using quantitative methods. The study found that five out of 27 golfers had a neurologic cause for their condition, with greater acceleration of wrist and arm movement and more variability in wrist acceleration and rotation.

SourceMayo Clinic·JournalMedicine & Science in Sports & Exercise·DateJul 19, 2018

Mayo discovery means individualized ovarian, brain cancer therapies

Researchers developed an algorithm to predict treatment effectiveness in individual patients using a molecular communication pathway. The study found that repurposing ruxolitinib, a drug approved for malignant blood disorders, can overcome resistance to measles virotherapy by increasing its effectiveness by a factor of 1,000.

SourceMayo Clinic·JournalJNCI Journal of the National Cancer Institute·DateMay 16, 2018

New oral anticoagulant drugs associated with lower kidney risks

Researchers found that non-vitamin K antagonist oral anticoagulants are associated with reduced risk of adverse kidney outcomes in patients with atrial fibrillation. The study, published in the Journal of the American College of Cardiology, showed that about 1 in 4 patients taking these medications experienced significant kidney functi...

SourceMayo Clinic·JournalJournal of the American College of Cardiology·DateNov 20, 2017